BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
597
- +12 vs. Q1 2026
- Total value $12.35B
Superinvestors holding TECH
3
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by TECH insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | May 8, 2026 | Herr Amy E.Director | SSaleCommon Stock | −6.64K | $48.28 | −$320.39K | 200 | −97.1% | SEC |
| Feb 19, 2026 | Feb 17, 2026 | Herr Amy E.Director | SSaleCommon Stock | −1.98K | $59.11 | −$116.8K | 200 | −90.8% | SEC |
| Aug 27, 2025 | Aug 25, 2025 | Nusse RoelandDirector | SSaleCommon Stock | −17.04K | $56.36 | −$960.37K | 44.56K | −27.7% | SEC |
| Aug 27, 2025 | Aug 25, 2025 | BAUMGARTNER ROBERT VDirector | SSaleCommon Stock | −17.04K | $56.21 | −$957.82K | 44.86K | −27.5% | SEC |
| Jun 11, 2025 | Jun 9, 2025 | Herr Amy E.Director | SSaleCommon Stock | −1.28K | $49.77 | −$63.71K | 1.98K | −39.3% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in TECH at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14,025,816 | $990.92M | 0.01% | +1,761,303+14.4% | Added |
| FMR LLC | 12,794,784 | $903.95M | 0.04% | +4,894,856+62.0% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 10,218,558 | $721.94M | 0.02% | +38,849+0.4% | Added |
| GOLDMAN SACHS GROUP INC | 7,343,324 | $518.81M | 0.05% | +5,399,790+277.8% | Added |
| HBK INVESTMENTS L P | 6,825,000 | $482.19M | 5.61% | +6,825,000 | New |